Latest News & Features
Americas
Allergan and InnoPharma settled patent litigation over Restasis (cyclosporine ophthalmic emulsion) yesterday, October 12, leaving three defendants still involved in a much publicised case. 13 October 2017
Americas
Allergan has until tomorrow, Friday October 13, to address the question of whether its patent licensing deal with a Native American tribe was a sham. 12 October 2017
article
Pharmaceutical company Sanofi has announced it is investing €170 million ($202 million) to expand an influenza vaccine production facility in France. 12 October 2017
Americas
Pfizer has revealed it is considering selling off its Consumer Healthcare business, a billion dollar over-the-counter company. 12 October 2017
Americas
The Broad Institute of Harvard and MIT has committed itself to tackling complex therapeutic challenges concerning unmet medical needs, while also signing a deal on technology. 12 October 2017
Medtech
Allograft tissue provider Musculoskeletal Transplant Foundation , a non-profit organisation, has announced that its patent dispute with biopharmaceutical company MiMedx will go to trial early next year. 11 October 2017
Americas
US-based law firm Phelps Dunbar has appointed Fenita Morris-Shepard as a counsel in its life sciences practice. 10 October 2017
Big Pharma
If the UK government changes the rules for clinical trials after Brexit, the regimes in the UK and the EU will diverge and possibly make trials more complex and costly, as Rachel Bradley of Penningtons Manches reports. 10 October 2017
Americas
Purdue Pharma has sued Collegium Pharmaceutical, in the latest development in a continuing patent infringement dispute centring on Purdue’s painkiller drug OxyContin. 10 October 2017
Biotechnology
Gilead Sciences has signed licensing agreements with the Medicines Patent Pool (MPP) and generic companies to provide greater access to HIV treatment bictegravir. 9 October 2017